Roche Holding AG (GB:0QOK)

LSE:0QOK

0QOK

Roche Holding AG

RESEARCH TOOLSreports

Roche Holding AG (0QOK) Share Forecast & Price Target

34 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0QOK Analyst Ratings

Moderate Buy

7 Buy

4 Hold

2 Sell

Based on 13 analysts giving stock ratings to

Roche

Holding AG

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0QOK Stock 12 Month Forecast

Average Price Target

CHF350.21

▲(11.48% Upside)

Based on 13 Wall Street analysts offering 12 month price targets for Roche Holding AG in the last 3 months. The average price target is CHF350.21 with a high forecast of CHF415.48 and a low forecast of CHF230.26. The average price target represents a 11.48% change from the last price of CHF314.16.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"229":"CHF229","416":"CHF416","275.75":"CHF275.8","322.5":"CHF322.5","369.25":"CHF369.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":415.4752465853835,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF415.48</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":350.214908082,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF350.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":230.263389673827,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF230.26</span>\n  </div></div>","useHTML":true}}],"tickPositions":[229,275.75,322.5,369.25,416],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jul<br/>2025","6":"Oct<br/>2025","9":"Jan<br/>2026","12":"Apr<br/>2026","25":"Apr<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,318.796,326.23286512195256,333.6697302439051,341.10659536585774,348.5434604878103,355.9803256097629,363.41719073171544,370.85405585366806,378.2909209756206,385.7277860975732,393.16465121952575,400.6015163414784,408.03838146343094,{"y":415.4752465853835,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,318.796,321.2128390832308,323.62967816646153,326.04651724969233,328.46335633292307,330.88019541615387,333.2970344993846,335.7138735826154,338.13071266584615,340.54755174907694,342.9643908323077,345.3812299155385,347.7980689987693,{"y":350.214908082,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,318.796,311.985799205679,305.175598411358,298.365397617037,291.55519682271597,284.744996028395,277.934795234074,271.12459443975297,264.314393645432,257.504192851111,250.69399205679,243.883791262469,237.07359046814798,{"y":230.263389673827,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":283.897,"date":1743465600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 18</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":262.105,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":257.808,"date":1748736000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 15</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":250.969,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":250.364,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":251.92,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":271.93,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 16</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":251.172,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 20</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":299.478,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 17</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":318.388,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 9</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":344.022,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":352.121,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":318.796,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF415.48

Average Price TargetCHF350.21

Lowest Price TargetCHF230.26

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Matthew Weston

UBS

CHF384

Buy

22.23%

Upside

Reiterated

04/10/26

UBS Remains a Buy on Roche Holding AG (RHHVF)

Justin Smith

Bernstein

CHF330→CHF395

Buy

25.73%

Upside

Reiterated

03/12/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Emmanuel Papadakis

Deutsche Bank

CHF340

Hold

8.23%

Upside

Reiterated

03/12/26

Analysts Are Neutral on These Healthcare Stocks: RegenXBio (RGNX), Roche Holding AG (RHHVF)

James Gordon CFA

Barclays

CHF410

Buy

30.51%

Upside

Reiterated

03/12/26

Barclays Remains a Buy on Roche Holding AG (RHHVF)

Richard Vosser

J.P. Morgan

CHF350→CHF325

Hold

3.45%

Upside

Reiterated

03/12/26

J.P. Morgan Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)

Luisa Hector

Berenberg Bank

CHF340

Hold

8.23%

Upside

Reiterated

03/11/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), Centene (NYSE: CNC) and LifeMD (NASDAQ: LFMD)

Unknown Analyst

HSBC

Not Ranked

HSBC

CHF385→CHF365

Buy

16.18%

Upside

Reiterated

03/10/26

Roche Holding AG target price reduced from CHF385 to CHF365, but we maintain our Buy rating due to pipeline catalysts.

Graham Parry

Citi

―

Buy

―

Reiterated

03/10/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)

David Evans

Kepler Capital

CHF415

Buy

32.10%

Upside

Reiterated

03/09/26

Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), Roche Holding AG (RHHVF)

Michael Leuchten

Jefferies

CHF230

Sell

-26.79%

Downside

Reiterated

03/09/26

Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (NASDAQ: IDYA) and Roche Holding AG (Other OTC: RHHVF)

James Quigley

Goldman Sachs

CHF349

Hold

11.09%

Upside

Reiterated

03/06/26

Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF) and Savara (NASDAQ: SVRA)

Sarita Kapila

Morgan Stanley

CHF295

Sell

-6.10%

Downside

Reiterated

03/02/26

Roche: Fenebrutinib Safety Concerns Skew Risk‑Reward, Driving Sell Rating

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

02/02/26

Analysts' Top Healthcare Picks: Nektar Therapeutics (NKTR), Roche Holding AG (RHHVF)

Peter Verdult

Exane BNP Paribas

CHF300

Buy

-4.51%

Downside

Initiated

04/16/25

BNP Paribas Exane Starts Roche Holding (ROG:SW) (RHHBY) at OutperformBNP Paribas Exane analyst Peter Verdult initiates coverage on Roche Holding (ROG:SW) (OTC: RHHBY) with a Outperform rating and a price target of CHF300.00.

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Matthew Weston

UBS

CHF384

Buy

22.23%

Upside

Reiterated

04/10/26

UBS Remains a Buy on Roche Holding AG (RHHVF)

Justin Smith

Bernstein

CHF330→CHF395

Buy

25.73%

Upside

Reiterated

03/12/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Emmanuel Papadakis

Deutsche Bank

CHF340

Hold

8.23%

Upside

Reiterated

03/12/26

Analysts Are Neutral on These Healthcare Stocks: RegenXBio (RGNX), Roche Holding AG (RHHVF)

James Gordon CFA

Barclays

CHF410

Buy

30.51%

Upside

Reiterated

03/12/26

Barclays Remains a Buy on Roche Holding AG (RHHVF)

Richard Vosser

J.P. Morgan

CHF350→CHF325

Hold

3.45%

Upside

Reiterated

03/12/26

J.P. Morgan Reaffirms Their Hold Rating on Roche Holding AG (RHHVF)

Luisa Hector

Berenberg Bank

CHF340

Hold

8.23%

Upside

Reiterated

03/11/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), Centene (NYSE: CNC) and LifeMD (NASDAQ: LFMD)

Unknown Analyst

HSBC

Not Ranked

HSBC

CHF385→CHF365

Buy

16.18%

Upside

Reiterated

03/10/26

Roche Holding AG target price reduced from CHF385 to CHF365, but we maintain our Buy rating due to pipeline catalysts.

Graham Parry

Citi

―

Buy

―

Reiterated

03/10/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF), BioNTech SE (NASDAQ: BNTX) and Skye Bioscience (NASDAQ: SKYE)

David Evans

Kepler Capital

CHF415

Buy

32.10%

Upside

Reiterated

03/09/26

Analysts Are Bullish on These Healthcare Stocks: IQVIA Holdings (IQV), Roche Holding AG (RHHVF)

Michael Leuchten

Jefferies

CHF230

Sell

-26.79%

Downside

Reiterated

03/09/26

Analysts Offer Insights on Healthcare Companies: IDEAYA Biosciences (NASDAQ: IDYA) and Roche Holding AG (Other OTC: RHHVF)

James Quigley

Goldman Sachs

CHF349

Hold

11.09%

Upside

Reiterated

03/06/26

Analysts Conflicted on These Healthcare Names: Roche Holding AG (Other OTC: RHHVF) and Savara (NASDAQ: SVRA)

Sarita Kapila

Morgan Stanley

CHF295

Sell

-6.10%

Downside

Reiterated

03/02/26

Roche: Fenebrutinib Safety Concerns Skew Risk‑Reward, Driving Sell Rating

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

02/02/26

Analysts' Top Healthcare Picks: Nektar Therapeutics (NKTR), Roche Holding AG (RHHVF)

Peter Verdult

Exane BNP Paribas

CHF300

Buy

-4.51%

Downside

Initiated

04/16/25

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Roche Holding AG

3 Months

xxx

Success Rate

12/15 ratings generated profit

Average Return

+7.15%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 80.00% of your transactions generating a profit, with an average return of +7.15% per trade.

1 Year

Matthew WestonUBS

Success Rate

12/12 ratings generated profit

Average Return

+29.78%

Copying Matthew Weston's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +29.78% per trade.

2 Years

xxx

Success Rate

15/15 ratings generated profit

Average Return

+35.11%

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +35.11% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0QOK Analyst Recommendation Trends

Rating

Dec 25

Jan 26

Feb 26

Mar 26

Apr 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0QOK has received 16 Buy Ratings, 11 Hold Ratings, and 5 Sell Ratings. 0QOK average Analyst price target in the past 3 months is 350.21.

Each month's total comprises the sum of three months' worth of ratings.

0QOK Financial Forecast

0QOK Earnings Forecast

Next quarter’s earnings estimate for 0QOK is CHF10.76 with a range of CHF10.71 to CHF10.80. The previous quarter’s EPS was CHF8.38. 0QOK beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year 0QOK has Performed in-line its overall industry.

0QOK Sales Forecast

Next quarter’s sales forecast for 0QOK is CHF31.20B with a range of CHF30.87B to CHF31.53B. The previous quarter’s sales results were CHF30.57B. 0QOK beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year 0QOK has Performed in-line its overall industry.

0QOK Stock Forecast FAQ

What is GB:0QOK’s average 12-month price target, according to analysts?

Based on analyst ratings, Roche Holding AG’s 12-month average price target is 350.21.

What is GB:0QOK’s upside potential, based on the analysts’ average price target?

Roche Holding AG has 11.48% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Roche Holding AG a Buy, Sell or Hold?

Roche Holding AG has a consensus rating of Moderate Buy, which is based on 7 buy ratings, 4 hold ratings and 2 sell ratings.

What is Roche Holding AG’s share price target?

The average share price target for Roche Holding AG is 350.21. This is based on 13 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF415.48 ,and the lowest forecast is CHF230.26. The average share price target represents 11.48% Increase from the current price of CHF314.16.

What do analysts say about Roche Holding AG?

Roche Holding AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 13 Wall Streets Analysts.

How can I buy shares of Roche Holding AG?

To buy shares of GB:0QOK, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Roche Holding AG (0QOK) Share Forecast & Price Target

0QOK Analyst Ratings

0QOK Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Roche Holding AG

0QOK Analyst Recommendation Trends

0QOK Financial Forecast

0QOK Earnings Forecast

0QOK Sales Forecast

0QOK Stock Forecast FAQ

Detailed List of Analyst Forecasts